Novo Nordisk A/S Class B

Novo Nordisk A/S Class B

42.18
USD
+1.99
(+4.95%)
3.99EPS
11.99P/E
212.88BMarket Cap
Feb 03Next Earn

Novo Nordisk A/S Class B Documents

Q4 FY2025 · Interim report

Novo Nordisk - Q4 2025 - Interim Report · February 4, 2026 · 43 pages

Read Novo Nordisk A/S Class B's results firsthand

Preview the first 2 pages of this interim report
Create a free account to start reading

Full documents are included with Professional

Q4 FY2025 documents